BRAMPTON, Ont. — Loblaw beat analyst forecasts for the quarter, the Financial Post reports, boosted by strong sales in its pharmacy business at Shoppers Drug Mart, which the retail group acquired this year. Same-store front sales grew 2.5% at Shoppers, while Loblaw saw overall 1.6% growth. Loblaw’s revenue rose 36% to $13.6 billion, a quarter of that coming from Shoppers Drug Mart. The merger saved Loblaw about $44 million in the quarter, but also cost it $46 million in restructuring and reorganization expenses. Net earnings fell to $142 million from $150 million. Adjusted basic net earnings was 90 cents per share, slightly ahead of the average forecast of 87 cents.
Shoppers deal buoys Loblaw results
Most Recent
Most Read
BMR kicks off buying show
Fri, November 08th, 2024
BMR member expands in Quebec
Fri, November 08th, 2024
Doman Building Materials announces Q3 results
Fri, November 08th, 2024
Canadian Tire reverses Q3 loss
Thu, November 07th, 2024
Register today for WRLA Showcase
Thu, November 07th, 2024
Western Forest Products posts Q3 loss
Thu, November 07th, 2024
In memoriam: Rick Royce
Thu, November 07th, 2024
Throwback Thursday: Ten years ago, Hardlines Conference focused on “retail as experience”
Thu, November 07th, 2024
Bernie Marcus, co-founder of The Home Depot, dies at 95
Wed, November 06th, 2024
Liteline appoints regional sales manager
Wed, November 06th, 2024